G0-C14

CAT:

804-HY-152229-02

Size:

10 mg

Price:

Ask

For price, please contact [email protected]

CAS Number: 1510653-27-6
UNSPSC Description: G0-C14 is a cationic lipid-like compound alkyl-modified polyamidoamine (PAMAM) dendrimer. G0-C14 involves in the preparation of a series of macrophage-targeted nanoparticles (NPs). NPs can be used for agent and vaccine delivery[1][2].
Target Antigen: Liposome
Type: Oligonucleotides
Related Pathways: Metabolic Enzyme/Protease
Applications: Cancer-programmed cell death
Field of Research: Cancer
Assay Protocol: https://www.medchemexpress.com/g0-c14.html
Solubility: DMSO : 100 mg/mL (ultrasonic;warming;heat to 80°C)
Smiles: O=C(CCN(CCN(CCC(NCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)=O)CCC(NCCNCC(CCCCCCCCCCCC)O)=O)CCC(NCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)=O)NCCNCC(CCCCCCCCCCCC)O
Molecular Weight: 1790.91
References & Citations: [1]Li S, et al. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials. 2020 Mar;234:119760. |[2]Chen Q, et al. Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy. J Control Release. 2020 Jul 10;323:179-190.
Shipping Conditions: Room Temperature
Clinical Information: No Development Reported